Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

Tokyo COVID: Cases surge as Delta variant takes hold, hospital policy U-turn expected

August 4, 2021 Medical Communications, Research and Development

Japan has warned that COVID-19 cases are surging at an ‘unprecedented pace’, hitting record highs in Tokyo amid the Olympic …
News

Delta surge: China reports highest rate of new COVID cases since Jan

August 4, 2021 Medical Communications, Research and Development

On Wednesday China reported the highest number of new locally transmitted COVID-19 cases since January, with case numbers being driven …
News

Novartis set to launch new Zolgensma trial to expand use

August 3, 2021 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novartis has announced that it will launch a new Phase III study to expand the use of Zolgensma – the …
News

Cannabis-based oral spray could kill brain tumours, study to launch next year

August 3, 2021 Manufacturing and Production, Medical Communications, Research and Development

The NHS alongside cancer charities are set to launch a clinical trial to investigate the effects of a cannabis-based oral …
News

CMA fines Advanz over £100 million over pricing of crucial thyroid drug

July 30, 2021 Medical Communications

The CMA has fined the pharmaceutical company Advanz over £100 million after it charged excessive and unfair prices for supplying …
News

FDA: Viatris’ insulin deemed ‘interchangeable’ biosimilar

July 30, 2021 Medical Communications

Viatris has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with …
News

COVID travel update: Double jabbed from US and EU could avoid UK quarantine

July 30, 2021 Medical Communications

UK ministers are close to deciding that double vaccinated people from the US and many EU countries will not have …
News

Positive data reported on Alnylam’s investigational RNAi therapeutic for ultra-rare disease

July 30, 2021 Medical Communications

Alnylam Pharmaceuticals has announced that its investigational RNAi therapeutic, lumasiran, has performed well in a Phase III study for the …
News

FDA grants Huntingdon disease treatment orphan-drug designation

July 30, 2021 Medical Communications

The FDA has granted VICO’s investigational therapy for Huntingdon disease, VO659, orphan-drug designation. This news comes just one month after …
News

Tokyo daily COVID cases hit record high

July 27, 2021 Manufacturing and Production, Medical Communications

On Tuesday Tokyo reported 2,848 daily coronavirus infections, the city’s highest rate since the pandemic began. The new infection record …
News

Antibodies from Sinovac’s COVID-19 vaccine fade after 6 months, study finds

July 27, 2021 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

A Chinese laboratory study has found that antibodies from Sinovac Biotech’s COVID-19 vaccine drop below a key threshold around six …
News

New NICE guideline on C. difficile rejects metronidazole prescription

July 23, 2021 Medical Communications

NICE has published a new guideline covering C. difficile infection, the latest in the series of antimicrobial prescribing guidelines which …
News
pfizer_building_logo2_1

Eight-week vaccine gap with Pfizer is best for antibodies

July 23, 2021 Medical Communications

UK researchers have found an eight-week gap between first and second doses of the Pfizer-BioNTech appears to be the “sweet …
News

Expansion for first FDA-approved video game for ADHD treatment

July 23, 2021 Medical Communications, Research and Development ADHD, FDA, US, digital therapeutics, technology

Akili Interactive has announced the expansion of its prescription video game treatment, EndeavorRx, with the addition of new gaming features …
News

Biogen pens open letter to Alzheimer’s community

July 23, 2021 Medical Communications

In the wake of the controversial approval of Biogen’s Alzheimer’s drug, Aduhelm, the company has penned an open letter to …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026